Back to mobile site
Get it on Google Play

FDA grants priority review to CorMedix's Rezzayo fungal prophylaxis sNDA

October 19, 2026 7:31 AM EDT Send to a Friend
CorMedix Therapeutics (Nasdaq: CRMD) announced that the U.S. Food and Drug Administration (FDA) has accepted for filing a supplemental New ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login